Printer Friendly

BERGEN BRUNSWIG REPORTS SECOND QUARTER AND SIX MONTH RESULTS

 BERGEN BRUNSWIG REPORTS SECOND QUARTER AND SIX MONTH RESULTS
 ORANGE, Calif., March 16 /PRNewswire/ -- Bergen Brunswig Corporation (AMEX: BBC) today reported results for the second fiscal quarter and the six months ended Feb. 29, 1992.
 Net sales and other revenues from continuing operations for the quarter ended Feb. 29, 1992, increased 17 percent to $1.22 billion from $1.05 billion for the comparable quarter last year. Net earnings for the quarter were $17.0 million compared to $17.1 million in the prior year quarter. Fully diluted earnings per share were $0.42 compared to $0.38 a year ago.
 Net earnings consisted of earnings from continuing operations of $15.5 million compared to $15.6 million in the comparable quarter last year, and earnings from discontinued operations, net of taxes on income, of $1.5 million for the quarter, the same as a year ago. Fully diluted earnings per share from continuing operations were $0.39 compared to $0.35 a year ago. Earnings from discontinued operations are those of Commtron Corporation, an approximately 81 percent-owned subsidiary. The company recently announced plans to sell Commtron to a wholly owned subsidiary of Ingram Industries, Inc.
 As a result of the previously announced stock repurchase program, the average number of shares used for primary earnings per share decreased to 37.6 million shares compared to 43.1 million shares for the prior year quarter.
 For the six months ended Feb. 29, 1992, net sales and other revenues from continuing operations increased 14 percent to $2.37 billion compared to $2.07 billion a year ago. Net earnings were equal to $25.9 million or $0.65 per fully diluted share, compared to $34.1 million and $0.75 per share in the 1991 period.
 For the six months ended Feb. 29, 1992, net earnings included earnings from continuing operations of $22.1 million or $0.57 per fully diluted share compared to $30.1 million or $0.67 in the comparable period last year. Earnings from discontinued operations were $3.8 million compared to $4.0 million for the prior year period.
 Robert E. Martini, president and chief executive officer, said, "The Company's results were on target for the quarter even though price increases on pharmaceuticals and the overall gross profit margin rate were lower than the prior year periods. One reason for the lower gross profit margin was a decrease in forward buying opportunities and increases in revenue coming from the hospital segment, where margins are slightly lower than for sales to chains and independent pharmacies. Operating expense as a percentage of sales was lower, while net interest expense for the quarter and the six month period was higher due to the increasing interest expense allocable on the LYONs Zero Coupon Convertibles and the lower interest income due to a declining interest rate environment."
 Bergen Brunswig Corporation is one of the nation's largest distributors of prescription pharmaceuticals and other health care products and, pending consummation of the sale of Commtron, the largest national distributor of prerecorded video cassettes.
 BERGEN BRUNSWIG CORPORATION AND SUBSIDIARIES
 Summary of Consolidated Sales and Earnings
 (Unaudited, in thousands except share and per share amounts)
 Second fiscal quarter ended: 2/29/92 2/28/91
 Net sales and other revenues: $1,219,888 $1,046,747
 Costs and expenses: 1,139,449 967,241
 Cost of sales
 Selling, general and
 administrative expenses 53,353 53,109
 Total costs and expenses $1,192,802 $1,020,350
 Operating earnings from
 continuing operations 27,086 26,397
 Net interest expense 2,470 1,744
 Earnings from continuing
 operations before taxes on income 24,616 24,653
 Taxes on income from continuing
 operations 9,108 9,043
 Earnings from continuing operations 15,508 15,610
 Earnings from discontinued
 operations, net of taxes on income(A) 1,490 1,486
 Net earnings $16,998 $17,096
 Average number of common and common
 equivalent shares(B):
 Primary 37,580,000 43,147,000
 Fully Diluted 45,356,000 50,929,000
 Earnings per share(B):
 Primary:
 Continuing Operations $.41 $.36
 Discontinued Operations $.04 $.04
 Net earnings $.45 $.40
 Fully Diluted:
 Continuing Operations $.39 $.35
 Discontinued Operations $.03 $.03
 Net earnings $.42 $.38
 NOTE: Addback to net earnings for fully diluted earnings per share computation:
 LYONs interest, net of tax effect $2,145 $2,034
 (A) -- On Feb. 24, 1992, the company signed a definitive agreement to sell its investment in Commtron Corporation. Accordingly, the results of operations of Commtron are shown as discontinued.
 (B) -- Gives effect to the 25 percent stock dividend declared July 17, 1991. Earnings per common and common equivalent share are based on the weighted average number of shares of Class A Common Stock outstanding during each period, the assumed conversion of the weighted average number of shares of Class B common stock outstanding during each period and the assumed exercise of employees' stock options. Fully diluted earnings per share assume conversion of the LYONs due 2004 (zero coupon-subordinated) from the issue date of Nov. 16, 1989.
 BERGEN BRUNSWIG CORPORATION AND SUBSIDIARIES
 Summary of Consolidated Sales and Earnings
 (Unaudited, in thousands except share and per share amounts)
 Six months ended 2/29/92 2/28/1991
 Net sales and other revenues: $2,369,109 $2,072,131
 Costs and expenses: 2,217,306 1,919,556
 Cost of sales
 Selling, general and
 administrative expenses 113,586 103,280
 Total costs and expenses $2,330,892 $2,022,836
 Operating earnings from
 continuing operations 38,217 49,295
 Net interest expense 3,475 1,856
 Earnings from continuing
 operations before taxes on
 income 34,742 47,439
 Taxes on income from continuing
 operations 12,622 17,344
 Earnings from continuing
 operations 22,120 30,095
 Earnings from discontinued
 operations, net of taxes on income(A) 3,765 3,989
 Net earnings $25,885 $34,084
 Average number of common and common
 equivalent shares(B):
 Primary 38,836,000 43,104,000
 Fully Diluted 46,608,000 50,904,000
 Earnings per share(B):
 Primary:
 Continuing Operations $.57 $.70
 Discontinued Operations $.10 $.09
 Net earnings $.67 $.79
 Fully Diluted:
 Continuing Operations $.57 $.67
 Discontinued Operations $.08 $.08
 Net earnings $.65 $.75
 NOTE: Addback to net earnings for fully diluted earnings per share computation:
 LYONs interest, net of tax effect $4,282 $4,015
 (A) -- On Feb. 24, 1992, the company signed a definitive agreement to sell its investment in Commtron Corporation. Accordingly, the results of operations of Commtron are shown as discontinued.
 (B) -- Gives effect to the 25 percent stock dividend declared July 17, 1991. Earnings per common and common equivalent share are based on the weighted average number of shares of Class A common stock outstanding during each period, the assumed conversion of the weighted average number of shares of Class B common stock outstanding during each period and the assumed exercise of employees' stock options. Fully diluted earnings per share assume conversion of the LYONs due 2004 (zero coupon-subordinated) from the issue date of Nov. 16, 1989.
 -0- 3/16/92
 /CONTACT: Neil F. Dimick, vice president, chief financial officer of Bergen Brunswig, 714-385-4000/
 (BBC) CO: Bergen Brunswig Corporation ST: California IN: MTC SU: ERN


TS -- NY012 -- 8106 03/16/92 08:20 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 16, 1992
Words:1206
Previous Article:NATURADE INC. EXTENDS CLASS A WARRANTS
Next Article:GENCORP REPORTS IMPROVED FIRST QUARTER RESULTS
Topics:


Related Articles
NET EARNINGS AT BERGEN BRUNSWIG WILL BE LESS THAN EXPECTED; SHARE REPURCHASE PLAN EXTENDED
BERGEN BRUNSWIG REPORTS FIRST QUARTER RESULTS
BERGEN BRUNSWIG REPORTS THIRD QUARTER AND NINE MONTH RESULTS
BERGEN BRUNSWIG REPORTS THIRD QUARTER AND NINE MONTH RESULTS
BERGEN BRUNSWIG REPORTS SECOND QUARTER AND FIRST HALF RESULTS
BERGEN BRUNSWIG REPORTS THIRD QUARTER AND NINE MONTHS RESULTS
BERGEN BRUNSWIG CORP. ANNOUNCES PRELIMINARY EARNINGS AND RESTRUCTURING OF DRUG DISTRIBUTION BUSINESS
BERGEN BRUNSWIG REPORTS FIRST QUARTER RESULTS
BERGEN BRUNSWIG REPORTS SECOND QUARTER AND SIX MONTH RESULTS
PharMerica Reports First Quarter 1999 Results.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters